Table 5.
Kaplan-Meier survivor functions by GS and PSAD (ng/ml/cm3).
| Group | Time (months) | Number at Risk (n) | Survivor Function | 95% CI |
|---|---|---|---|---|
| 0 | 161 | 1.00 ± 0 | 0.00 | |
| GS 3+3 | 12 | 107 | 0.97 ± 0.02 | 0.92–0.99 |
| PSAD < 0.15 | 24 | 59 | 0.93 ± 0.02 | 0.86–0.97 |
| 36 | 21 | 0.85 ± 0.05 | 0.71–0.93 | |
|
| ||||
| 0 | 35 | 1.00 ± 0 | 0.00 | |
| GS 3+3 | 12 | 21 | 0.92 ± 0.05 | 0.73–0.98 |
| PSAD ≥ 0.15 | 24 | 7 | 0.73 ± 0.11 | 0.43–0.89 |
| 36 | 3 | 0.73 ± 0.11 | 0.43–0.89 | |
|
| ||||
| 0 | 39 | 1.00 ± 0 | 0.00 | |
| GS 3+4 | 12 | 20 | 0.88 ± 0.06 | 0.72–0.95 |
| PSAD < 0.15 | 24 | 8 | 0.77 ± 0.11 | 0.45–0.92 |
| 36 | 7 | 0.66 ± 0.14 | 0.32–0.86 | |
|
| ||||
| 0 | 24 | 1.00 ± 0 | 0.00 | |
| GS 3+4 | 12 | 8 | 0.59 ± 0.13 | 0.31–0.79 |
| PSAD ≥ 0.15 | 24 | 1 | 0.39 ± 0.18 | 0.09–0.70 |